The authors have been made aware that two figures were published in two papers: Figure 5A in paper [1] is duplicated as Figure 3D in published paper [2], and Figure 3A in paper [1] is duplicated as Figure 3A in published paper [2]. The authors state this was due to carelessness. In order to preserve academic integrity, the Antibiotics Editorial Office has taken the decision to retract the paper with the consent of the authors. The authors assert that the findings, that vanillic acid exerted a significant antibacterial activity against carbapenem-resistant Enterobacter cloacae (CREC), are nevertheless reliable [1].
The Editor-in-Chief has checked the case and communicated with the authors. The decision to retract has been taken in agreement with the authors of the paper [1]. The Antibiotics Editorial Office and authors apologize to the readers of Antibiotics for any inconvenience caused.
To ensure the addition of only high-quality scientific works to the field of scholarly publication, this paper [1] is retracted and shall be marked accordingly. MDPI is a member of the Committee on Publication Ethics (COPE) and takes very seriously the responsibility to enforce strict ethical policies and standards.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- 1.Qian W., Fu Y., Liu M., Wang T., Zhang J., Yang M., Sun Z., Li X., Li Y. In Vitro Antibacterial Activity and Mechanism of Vanillic Acid against Carbapenem-Resistant Enterobacter cloacae. Antibiotics. 2019;8:220. doi: 10.3390/antibiotics8040220. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 2.Qian W., Li X., Shen L., Wang T., Liu M., Zhang J., Yang M., Li X., Cai C. Antibacterial and Antibiofilm Activity of Ursolic Acid Against Carbapenem-Resistant Enterobacter cloacae. J. Biosci. Bioeng. 2020;129:528–534. doi: 10.1016/j.jbiosc.2019.11.008. [DOI] [PubMed] [Google Scholar]